Canopy Growth (CGC) director granted 42,658 RSUs; vesting set
Canopy Growth (CGC) disclosed an insider equity grant on a Form 4.
Rhea-AI Filing Summary
Canopy Growth (CGC) disclosed an insider equity grant on a Form 4. A director received 42,658 restricted stock units (RSUs) on November 11, 2025 at a price of $0, reflecting a non-cash award.
The filing notes a staggered vesting schedule: 20,158 RSUs vest on December 31, 2025 and 22,500 RSUs vest on March 31, 2026. Following the grant, the director reported 42,658 shares beneficially owned, held directly. This is routine equity compensation and does not involve cash proceeds.
Positive
- None.
Negative
- None.
Insights
Routine RSU grant to a director with two vesting dates.
The Form 4 records a non-cash award of 42,658 RSUs granted on November 11, 2025. RSUs are rights to receive shares upon vesting, commonly used to align director incentives with shareholders.
Vesting occurs in two tranches: 20,158 on December 31, 2025 and 22,500 on March 31, 2026. Any dilution impact would depend on share delivery at vesting and is typically modest for single-director awards.
The transaction price is $0, consistent with equity grants. This filing is administrative in nature and does not indicate operational or financial changes.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 42,658 | $0.00 | $0.00 |
Footnotes (1)
- F1. The shares reported herein were granted on November 11, 2025, in the form of restricted stock units ("RSUs"). 20,158 of the RSUs will vest on December 31, 2025 and 22,500 will vest on March 31, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CGC report?
What is the vesting schedule for the 42,658 RSUs at CGC?
Was there a purchase price for the CGC RSU grant?
What role does the reporting person hold at CGC?
Does this filing indicate cash proceeds to CGC?
AI-generated analysis. How Rhea-AI works. Not financial advice.